By Ben Glickman Shares of Cidara Therapeutics rose sharply after the company announced a reshuffling of its portfolio of drug candidates. The stock was up 42% to $17.50 in after-hours.
Adagrasib, Cetuximab May Benefit KRASG12c Colorectal Cancer Patients miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
US Physicians Received Billions From Pharmaceutical and Medical Device Industry, New Research Finds theepochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theepochtimes.com Daily Mail and Mail on Sunday newspapers.